MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $622,237,000 | +47.8% | 11,856,648 | -6.3% | 0.02% | +40.0% |
Q2 2020 | $421,030,000 | +26.4% | 12,654,956 | +3.4% | 0.02% | +7.1% |
Q1 2020 | $332,992,000 | +41.6% | 12,242,330 | +2.7% | 0.01% | +75.0% |
Q4 2019 | $235,178,000 | +72.0% | 11,919,788 | +13.0% | 0.01% | +60.0% |
Q3 2019 | $136,715,000 | +5.2% | 10,549,049 | +1.1% | 0.01% | 0.0% |
Q2 2019 | $129,931,000 | -13.2% | 10,436,152 | +1.3% | 0.01% | -16.7% |
Q1 2019 | $149,751,000 | +39.6% | 10,306,390 | +6.1% | 0.01% | +20.0% |
Q4 2018 | $107,243,000 | -46.3% | 9,713,976 | +27.8% | 0.01% | -37.5% |
Q3 2018 | $199,827,000 | +33.5% | 7,597,950 | +3.8% | 0.01% | +33.3% |
Q2 2018 | $149,649,000 | +18.4% | 7,317,773 | +5.1% | 0.01% | 0.0% |
Q1 2018 | $126,392,000 | +32.6% | 6,963,833 | +1.9% | 0.01% | +50.0% |
Q4 2017 | $95,307,000 | -21.8% | 6,831,994 | +3.7% | 0.00% | -33.3% |
Q3 2017 | $121,860,000 | +15.5% | 6,587,051 | +5.5% | 0.01% | +20.0% |
Q2 2017 | $105,519,000 | +32.8% | 6,243,767 | +4.9% | 0.01% | +25.0% |
Q1 2017 | $79,481,000 | -8.3% | 5,953,677 | +3.4% | 0.00% | -20.0% |
Q4 2016 | $86,654,000 | +43.7% | 5,757,681 | +11.6% | 0.01% | +25.0% |
Q3 2016 | $60,293,000 | +17.5% | 5,157,691 | +8.6% | 0.00% | +33.3% |
Q2 2016 | $51,309,000 | +11.8% | 4,750,816 | -4.3% | 0.00% | 0.0% |
Q1 2016 | $45,892,000 | -36.1% | 4,966,716 | +2.6% | 0.00% | -40.0% |
Q4 2015 | $71,831,000 | -7.0% | 4,840,306 | +2.8% | 0.01% | +66.7% |
Q3 2015 | $77,259,000 | -21.9% | 4,708,049 | +8.5% | 0.00% | -57.1% |
Q2 2015 | $98,935,000 | +95.7% | 4,337,388 | +30.4% | 0.01% | +133.3% |
Q1 2015 | $50,552,000 | +37.2% | 3,325,801 | +8.7% | 0.00% | 0.0% |
Q4 2014 | $36,854,000 | +3.2% | 3,060,995 | -2.8% | 0.00% | 0.0% |
Q3 2014 | $35,709,000 | -5.1% | 3,149,008 | +1.1% | 0.00% | 0.0% |
Q2 2014 | $37,617,000 | +0.7% | 3,114,017 | -2.9% | 0.00% | 0.0% |
Q1 2014 | $37,356,000 | -30.8% | 3,206,535 | +5.0% | 0.00% | -40.0% |
Q4 2013 | $53,977,000 | +27.7% | 3,053,006 | +3.9% | 0.01% | +25.0% |
Q3 2013 | $42,266,000 | +1.1% | 2,937,147 | +5.8% | 0.00% | 0.0% |
Q2 2013 | $41,801,000 | – | 2,775,604 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |